Drugs / NANOVAE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06606561 | Oct 2026 → Apr 2027 expected | osteoarthritis, knee | Nova Vita Laboratory | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NANOVAE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06606561 ↗ |
| Route | Other | “Route of Administration: Intra-articular Injections.” NCT06606561 ↗ |